Global Rabies Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Rabies Vaccine market size was valued at US$ 910.8 million in 2023. With growing demand in downstream market, the Rabies Vaccine is forecast to a readjusted size of US$ 1210.6 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Rabies Vaccine market. Rabies Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rabies Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rabies Vaccine market.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Key Features:
The report on Rabies Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Rabies Vaccine market. It may include historical data, market segmentation by Type (e.g., Vero Cell Rabies Vaccine, BHK), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rabies Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Rabies Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Rabies Vaccine industry. This include advancements in Rabies Vaccine technology, Rabies Vaccine new entrants, Rabies Vaccine new investment, and other innovations that are shaping the future of Rabies Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rabies Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Rabies Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rabies Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rabies Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rabies Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rabies Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rabies Vaccine market.
Market Segmentation:
Rabies Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Rabies Vaccine market?
What factors are driving Rabies Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Vaccine market opportunities vary by end market size?
How does Rabies Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Rabies Vaccine market size was valued at US$ 910.8 million in 2023. With growing demand in downstream market, the Rabies Vaccine is forecast to a readjusted size of US$ 1210.6 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Rabies Vaccine market. Rabies Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rabies Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rabies Vaccine market.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Key Features:
The report on Rabies Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Rabies Vaccine market. It may include historical data, market segmentation by Type (e.g., Vero Cell Rabies Vaccine, BHK), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rabies Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Rabies Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Rabies Vaccine industry. This include advancements in Rabies Vaccine technology, Rabies Vaccine new entrants, Rabies Vaccine new investment, and other innovations that are shaping the future of Rabies Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rabies Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Rabies Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rabies Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rabies Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rabies Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rabies Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rabies Vaccine market.
Market Segmentation:
Rabies Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Vero Cell Rabies Vaccine
- BHK
- Chick Embryo Cell Rabies Vaccine
- Others
- Pre-exposure Prophylaxis
- Post-exposure Prophylaxis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK (Novartis)
- Sanofi-Pasteur
- Chengda
- Yisheng
- Prcmise
- VACN
- Changsheng
- BCHT
- Hissen
What is the 10-year outlook for the global Rabies Vaccine market?
What factors are driving Rabies Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Vaccine market opportunities vary by end market size?
How does Rabies Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rabies Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rabies Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Rabies Vaccine Segment by Type
2.2.1 Vero Cell Rabies Vaccine
2.2.2 BHK
2.2.3 Chick Embryo Cell Rabies Vaccine
2.2.4 Others
2.3 Rabies Vaccine Sales by Type
2.3.1 Global Rabies Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Rabies Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Rabies Vaccine Sale Price by Type (2019-2024)
2.4 Rabies Vaccine Segment by Application
2.4.1 Pre-exposure Prophylaxis
2.4.2 Post-exposure Prophylaxis
2.5 Rabies Vaccine Sales by Application
2.5.1 Global Rabies Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Rabies Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Rabies Vaccine Sale Price by Application (2019-2024)
3 GLOBAL RABIES VACCINE BY COMPANY
3.1 Global Rabies Vaccine Breakdown Data by Company
3.1.1 Global Rabies Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Rabies Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Rabies Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Rabies Vaccine Revenue by Company (2019-2024)
3.2.2 Global Rabies Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Rabies Vaccine Sale Price by Company
3.4 Key Manufacturers Rabies Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Vaccine Product Location Distribution
3.4.2 Players Rabies Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RABIES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Rabies Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Rabies Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rabies Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rabies Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Rabies Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rabies Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rabies Vaccine Sales Growth
4.4 APAC Rabies Vaccine Sales Growth
4.5 Europe Rabies Vaccine Sales Growth
4.6 Middle East & Africa Rabies Vaccine Sales Growth
5 AMERICAS
5.1 Americas Rabies Vaccine Sales by Country
5.1.1 Americas Rabies Vaccine Sales by Country (2019-2024)
5.1.2 Americas Rabies Vaccine Revenue by Country (2019-2024)
5.2 Americas Rabies Vaccine Sales by Type
5.3 Americas Rabies Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Vaccine Sales by Region
6.1.1 APAC Rabies Vaccine Sales by Region (2019-2024)
6.1.2 APAC Rabies Vaccine Revenue by Region (2019-2024)
6.2 APAC Rabies Vaccine Sales by Type
6.3 APAC Rabies Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Vaccine by Country
7.1.1 Europe Rabies Vaccine Sales by Country (2019-2024)
7.1.2 Europe Rabies Vaccine Revenue by Country (2019-2024)
7.2 Europe Rabies Vaccine Sales by Type
7.3 Europe Rabies Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Vaccine by Country
8.1.1 Middle East & Africa Rabies Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rabies Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Rabies Vaccine Sales by Type
8.3 Middle East & Africa Rabies Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Vaccine
10.3 Manufacturing Process Analysis of Rabies Vaccine
10.4 Industry Chain Structure of Rabies Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Vaccine Distributors
11.3 Rabies Vaccine Customer
12 WORLD FORECAST REVIEW FOR RABIES VACCINE BY GEOGRAPHIC REGION
12.1 Global Rabies Vaccine Market Size Forecast by Region
12.1.1 Global Rabies Vaccine Forecast by Region (2025-2030)
12.1.2 Global Rabies Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Vaccine Forecast by Type
12.7 Global Rabies Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK (Novartis)
13.1.1 GSK (Novartis) Company Information
13.1.2 GSK (Novartis) Rabies Vaccine Product Portfolios and Specifications
13.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK (Novartis) Main Business Overview
13.1.5 GSK (Novartis) Latest Developments
13.2 Sanofi-Pasteur
13.2.1 Sanofi-Pasteur Company Information
13.2.2 Sanofi-Pasteur Rabies Vaccine Product Portfolios and Specifications
13.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi-Pasteur Main Business Overview
13.2.5 Sanofi-Pasteur Latest Developments
13.3 Chengda
13.3.1 Chengda Company Information
13.3.2 Chengda Rabies Vaccine Product Portfolios and Specifications
13.3.3 Chengda Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chengda Main Business Overview
13.3.5 Chengda Latest Developments
13.4 Yisheng
13.4.1 Yisheng Company Information
13.4.2 Yisheng Rabies Vaccine Product Portfolios and Specifications
13.4.3 Yisheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Yisheng Main Business Overview
13.4.5 Yisheng Latest Developments
13.5 Prcmise
13.5.1 Prcmise Company Information
13.5.2 Prcmise Rabies Vaccine Product Portfolios and Specifications
13.5.3 Prcmise Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Prcmise Main Business Overview
13.5.5 Prcmise Latest Developments
13.6 VACN
13.6.1 VACN Company Information
13.6.2 VACN Rabies Vaccine Product Portfolios and Specifications
13.6.3 VACN Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 VACN Main Business Overview
13.6.5 VACN Latest Developments
13.7 Changsheng
13.7.1 Changsheng Company Information
13.7.2 Changsheng Rabies Vaccine Product Portfolios and Specifications
13.7.3 Changsheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Changsheng Main Business Overview
13.7.5 Changsheng Latest Developments
13.8 BCHT
13.8.1 BCHT Company Information
13.8.2 BCHT Rabies Vaccine Product Portfolios and Specifications
13.8.3 BCHT Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 BCHT Main Business Overview
13.8.5 BCHT Latest Developments
13.9 Hissen
13.9.1 Hissen Company Information
13.9.2 Hissen Rabies Vaccine Product Portfolios and Specifications
13.9.3 Hissen Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hissen Main Business Overview
13.9.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rabies Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rabies Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Rabies Vaccine Segment by Type
2.2.1 Vero Cell Rabies Vaccine
2.2.2 BHK
2.2.3 Chick Embryo Cell Rabies Vaccine
2.2.4 Others
2.3 Rabies Vaccine Sales by Type
2.3.1 Global Rabies Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Rabies Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Rabies Vaccine Sale Price by Type (2019-2024)
2.4 Rabies Vaccine Segment by Application
2.4.1 Pre-exposure Prophylaxis
2.4.2 Post-exposure Prophylaxis
2.5 Rabies Vaccine Sales by Application
2.5.1 Global Rabies Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Rabies Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Rabies Vaccine Sale Price by Application (2019-2024)
3 GLOBAL RABIES VACCINE BY COMPANY
3.1 Global Rabies Vaccine Breakdown Data by Company
3.1.1 Global Rabies Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Rabies Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Rabies Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Rabies Vaccine Revenue by Company (2019-2024)
3.2.2 Global Rabies Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Rabies Vaccine Sale Price by Company
3.4 Key Manufacturers Rabies Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Vaccine Product Location Distribution
3.4.2 Players Rabies Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RABIES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Rabies Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Rabies Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rabies Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rabies Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Rabies Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rabies Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rabies Vaccine Sales Growth
4.4 APAC Rabies Vaccine Sales Growth
4.5 Europe Rabies Vaccine Sales Growth
4.6 Middle East & Africa Rabies Vaccine Sales Growth
5 AMERICAS
5.1 Americas Rabies Vaccine Sales by Country
5.1.1 Americas Rabies Vaccine Sales by Country (2019-2024)
5.1.2 Americas Rabies Vaccine Revenue by Country (2019-2024)
5.2 Americas Rabies Vaccine Sales by Type
5.3 Americas Rabies Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Vaccine Sales by Region
6.1.1 APAC Rabies Vaccine Sales by Region (2019-2024)
6.1.2 APAC Rabies Vaccine Revenue by Region (2019-2024)
6.2 APAC Rabies Vaccine Sales by Type
6.3 APAC Rabies Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Vaccine by Country
7.1.1 Europe Rabies Vaccine Sales by Country (2019-2024)
7.1.2 Europe Rabies Vaccine Revenue by Country (2019-2024)
7.2 Europe Rabies Vaccine Sales by Type
7.3 Europe Rabies Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Vaccine by Country
8.1.1 Middle East & Africa Rabies Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rabies Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Rabies Vaccine Sales by Type
8.3 Middle East & Africa Rabies Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Vaccine
10.3 Manufacturing Process Analysis of Rabies Vaccine
10.4 Industry Chain Structure of Rabies Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Vaccine Distributors
11.3 Rabies Vaccine Customer
12 WORLD FORECAST REVIEW FOR RABIES VACCINE BY GEOGRAPHIC REGION
12.1 Global Rabies Vaccine Market Size Forecast by Region
12.1.1 Global Rabies Vaccine Forecast by Region (2025-2030)
12.1.2 Global Rabies Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Vaccine Forecast by Type
12.7 Global Rabies Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK (Novartis)
13.1.1 GSK (Novartis) Company Information
13.1.2 GSK (Novartis) Rabies Vaccine Product Portfolios and Specifications
13.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK (Novartis) Main Business Overview
13.1.5 GSK (Novartis) Latest Developments
13.2 Sanofi-Pasteur
13.2.1 Sanofi-Pasteur Company Information
13.2.2 Sanofi-Pasteur Rabies Vaccine Product Portfolios and Specifications
13.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi-Pasteur Main Business Overview
13.2.5 Sanofi-Pasteur Latest Developments
13.3 Chengda
13.3.1 Chengda Company Information
13.3.2 Chengda Rabies Vaccine Product Portfolios and Specifications
13.3.3 Chengda Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chengda Main Business Overview
13.3.5 Chengda Latest Developments
13.4 Yisheng
13.4.1 Yisheng Company Information
13.4.2 Yisheng Rabies Vaccine Product Portfolios and Specifications
13.4.3 Yisheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Yisheng Main Business Overview
13.4.5 Yisheng Latest Developments
13.5 Prcmise
13.5.1 Prcmise Company Information
13.5.2 Prcmise Rabies Vaccine Product Portfolios and Specifications
13.5.3 Prcmise Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Prcmise Main Business Overview
13.5.5 Prcmise Latest Developments
13.6 VACN
13.6.1 VACN Company Information
13.6.2 VACN Rabies Vaccine Product Portfolios and Specifications
13.6.3 VACN Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 VACN Main Business Overview
13.6.5 VACN Latest Developments
13.7 Changsheng
13.7.1 Changsheng Company Information
13.7.2 Changsheng Rabies Vaccine Product Portfolios and Specifications
13.7.3 Changsheng Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Changsheng Main Business Overview
13.7.5 Changsheng Latest Developments
13.8 BCHT
13.8.1 BCHT Company Information
13.8.2 BCHT Rabies Vaccine Product Portfolios and Specifications
13.8.3 BCHT Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 BCHT Main Business Overview
13.8.5 BCHT Latest Developments
13.9 Hissen
13.9.1 Hissen Company Information
13.9.2 Hissen Rabies Vaccine Product Portfolios and Specifications
13.9.3 Hissen Rabies Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hissen Main Business Overview
13.9.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rabies Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Rabies Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Vero Cell Rabies Vaccine
Table 4. Major Players of BHK
Table 5. Major Players of Chick Embryo Cell Rabies Vaccine
Table 6. Major Players of Others
Table 7. Global Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 8. Global Rabies Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Rabies Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Rabies Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Rabies Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 13. Global Rabies Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Rabies Vaccine Revenue by Application (2019-2024)
Table 15. Global Rabies Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Rabies Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Rabies Vaccine Sales by Company (2019-2024) & (K Units)
Table 18. Global Rabies Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Rabies Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Rabies Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Rabies Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Rabies Vaccine Producing Area Distribution and Sales Area
Table 23. Players Rabies Vaccine Products Offered
Table 24. Rabies Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rabies Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Rabies Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Rabies Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Rabies Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Rabies Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Rabies Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Rabies Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Rabies Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Rabies Vaccine Sales by Country (2019-2024) & (K Units)
Table 36. Americas Rabies Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Rabies Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Rabies Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 40. Americas Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 41. APAC Rabies Vaccine Sales by Region (2019-2024) & (K Units)
Table 42. APAC Rabies Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Rabies Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Rabies Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. APAC Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Europe Rabies Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Europe Rabies Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Rabies Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Rabies Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 52. Europe Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Rabies Vaccine Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Rabies Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Rabies Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Rabies Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rabies Vaccine
Table 60. Key Market Challenges & Risks of Rabies Vaccine
Table 61. Key Industry Trends of Rabies Vaccine
Table 62. Rabies Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rabies Vaccine Distributors List
Table 65. Rabies Vaccine Customer List
Table 66. Global Rabies Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Rabies Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Rabies Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Rabies Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Rabies Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Rabies Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Rabies Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Rabies Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Rabies Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Rabies Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Rabies Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Rabies Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Rabies Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Rabies Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. GSK (Novartis) Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK (Novartis) Rabies Vaccine Product Portfolios and Specifications
Table 82. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GSK (Novartis) Main Business
Table 84. GSK (Novartis) Latest Developments
Table 85. Sanofi-Pasteur Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi-Pasteur Rabies Vaccine Product Portfolios and Specifications
Table 87. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi-Pasteur Main Business
Table 89. Sanofi-Pasteur Latest Developments
Table 90. Chengda Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Chengda Rabies Vaccine Product Portfolios and Specifications
Table 92. Chengda Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Chengda Main Business
Table 94. Chengda Latest Developments
Table 95. Yisheng Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Yisheng Rabies Vaccine Product Portfolios and Specifications
Table 97. Yisheng Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Yisheng Main Business
Table 99. Yisheng Latest Developments
Table 100. Prcmise Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Prcmise Rabies Vaccine Product Portfolios and Specifications
Table 102. Prcmise Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Prcmise Main Business
Table 104. Prcmise Latest Developments
Table 105. VACN Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. VACN Rabies Vaccine Product Portfolios and Specifications
Table 107. VACN Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. VACN Main Business
Table 109. VACN Latest Developments
Table 110. Changsheng Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Changsheng Rabies Vaccine Product Portfolios and Specifications
Table 112. Changsheng Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Changsheng Main Business
Table 114. Changsheng Latest Developments
Table 115. BCHT Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. BCHT Rabies Vaccine Product Portfolios and Specifications
Table 117. BCHT Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BCHT Main Business
Table 119. BCHT Latest Developments
Table 120. Hissen Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Hissen Rabies Vaccine Product Portfolios and Specifications
Table 122. Hissen Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Hissen Main Business
Table 124. Hissen Latest Developments
Table 1. Rabies Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Rabies Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Vero Cell Rabies Vaccine
Table 4. Major Players of BHK
Table 5. Major Players of Chick Embryo Cell Rabies Vaccine
Table 6. Major Players of Others
Table 7. Global Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 8. Global Rabies Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Rabies Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Rabies Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Rabies Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 13. Global Rabies Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Rabies Vaccine Revenue by Application (2019-2024)
Table 15. Global Rabies Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Rabies Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Rabies Vaccine Sales by Company (2019-2024) & (K Units)
Table 18. Global Rabies Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Rabies Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Rabies Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Rabies Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Rabies Vaccine Producing Area Distribution and Sales Area
Table 23. Players Rabies Vaccine Products Offered
Table 24. Rabies Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rabies Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Rabies Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Rabies Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Rabies Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Rabies Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Rabies Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Rabies Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Rabies Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Rabies Vaccine Sales by Country (2019-2024) & (K Units)
Table 36. Americas Rabies Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Rabies Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Rabies Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 40. Americas Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 41. APAC Rabies Vaccine Sales by Region (2019-2024) & (K Units)
Table 42. APAC Rabies Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Rabies Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Rabies Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. APAC Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Europe Rabies Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Europe Rabies Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Rabies Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Rabies Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 52. Europe Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Rabies Vaccine Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Rabies Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Rabies Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Rabies Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Rabies Vaccine Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Rabies Vaccine Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rabies Vaccine
Table 60. Key Market Challenges & Risks of Rabies Vaccine
Table 61. Key Industry Trends of Rabies Vaccine
Table 62. Rabies Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rabies Vaccine Distributors List
Table 65. Rabies Vaccine Customer List
Table 66. Global Rabies Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Rabies Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Rabies Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Rabies Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Rabies Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Rabies Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Rabies Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Rabies Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Rabies Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Rabies Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Rabies Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Rabies Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Rabies Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Rabies Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. GSK (Novartis) Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK (Novartis) Rabies Vaccine Product Portfolios and Specifications
Table 82. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GSK (Novartis) Main Business
Table 84. GSK (Novartis) Latest Developments
Table 85. Sanofi-Pasteur Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi-Pasteur Rabies Vaccine Product Portfolios and Specifications
Table 87. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi-Pasteur Main Business
Table 89. Sanofi-Pasteur Latest Developments
Table 90. Chengda Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Chengda Rabies Vaccine Product Portfolios and Specifications
Table 92. Chengda Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Chengda Main Business
Table 94. Chengda Latest Developments
Table 95. Yisheng Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Yisheng Rabies Vaccine Product Portfolios and Specifications
Table 97. Yisheng Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Yisheng Main Business
Table 99. Yisheng Latest Developments
Table 100. Prcmise Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Prcmise Rabies Vaccine Product Portfolios and Specifications
Table 102. Prcmise Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Prcmise Main Business
Table 104. Prcmise Latest Developments
Table 105. VACN Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. VACN Rabies Vaccine Product Portfolios and Specifications
Table 107. VACN Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. VACN Main Business
Table 109. VACN Latest Developments
Table 110. Changsheng Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Changsheng Rabies Vaccine Product Portfolios and Specifications
Table 112. Changsheng Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Changsheng Main Business
Table 114. Changsheng Latest Developments
Table 115. BCHT Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. BCHT Rabies Vaccine Product Portfolios and Specifications
Table 117. BCHT Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BCHT Main Business
Table 119. BCHT Latest Developments
Table 120. Hissen Basic Information, Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Hissen Rabies Vaccine Product Portfolios and Specifications
Table 122. Hissen Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Hissen Main Business
Table 124. Hissen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rabies Vaccine
Figure 2. Rabies Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Rabies Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Rabies Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Vero Cell Rabies Vaccine
Figure 10. Product Picture of BHK
Figure 11. Product Picture of Chick Embryo Cell Rabies Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Rabies Vaccine Sales Market Share by Type in 2023
Figure 14. Global Rabies Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Rabies Vaccine Consumed in Pre-exposure Prophylaxis
Figure 16. Global Rabies Vaccine Market: Pre-exposure Prophylaxis (2019-2024) & (K Units)
Figure 17. Rabies Vaccine Consumed in Post-exposure Prophylaxis
Figure 18. Global Rabies Vaccine Market: Post-exposure Prophylaxis (2019-2024) & (K Units)
Figure 19. Global Rabies Vaccine Sales Market Share by Application (2023)
Figure 20. Global Rabies Vaccine Revenue Market Share by Application in 2023
Figure 21. Rabies Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Rabies Vaccine Sales Market Share by Company in 2023
Figure 23. Rabies Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Rabies Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Rabies Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Rabies Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Rabies Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Rabies Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Rabies Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Rabies Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Rabies Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Rabies Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Rabies Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Rabies Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Rabies Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Rabies Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Rabies Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Rabies Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Rabies Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Rabies Vaccine
Figure 74. Industry Chain Structure of Rabies Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Rabies Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Rabies Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Rabies Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Rabies Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Rabies Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Rabies Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Rabies Vaccine
Figure 2. Rabies Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Rabies Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Rabies Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Vero Cell Rabies Vaccine
Figure 10. Product Picture of BHK
Figure 11. Product Picture of Chick Embryo Cell Rabies Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Rabies Vaccine Sales Market Share by Type in 2023
Figure 14. Global Rabies Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Rabies Vaccine Consumed in Pre-exposure Prophylaxis
Figure 16. Global Rabies Vaccine Market: Pre-exposure Prophylaxis (2019-2024) & (K Units)
Figure 17. Rabies Vaccine Consumed in Post-exposure Prophylaxis
Figure 18. Global Rabies Vaccine Market: Post-exposure Prophylaxis (2019-2024) & (K Units)
Figure 19. Global Rabies Vaccine Sales Market Share by Application (2023)
Figure 20. Global Rabies Vaccine Revenue Market Share by Application in 2023
Figure 21. Rabies Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Rabies Vaccine Sales Market Share by Company in 2023
Figure 23. Rabies Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Rabies Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Rabies Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Rabies Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Rabies Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Rabies Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Rabies Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Rabies Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Rabies Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Rabies Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Rabies Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Rabies Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Rabies Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Rabies Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Rabies Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Rabies Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Rabies Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Rabies Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Rabies Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Rabies Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Rabies Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Rabies Vaccine
Figure 74. Industry Chain Structure of Rabies Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Rabies Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Rabies Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Rabies Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Rabies Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Rabies Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Rabies Vaccine Revenue Market Share Forecast by Application (2025-2030)
